UNSPSC 51162715: Guaiacol benzoate

This classification denotes a topical anti-infective agent and expectorant with the molecular formula C14H12O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ODW913ZA6P, chemically known as phenol, 2-methoxy-, 1-benzoate, but more generally known as guaiacol benzoate, which bears US NIH Compound Identifier 68272. European Medicines Agency schedules guaiacol benzoate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14027MIG.

Most nations, for tariff purposes, schedule guaiacol benzoate under HS 29095000. SMILES: COC1CCCCC1OC(=O)C2CCCCC2.

UNSPSC 51162715 Guaiacol benzoate is a Commodity code showing minimal alignment with recent state and local procurement activity. The code nominally covers a specific chemical compound, yet the two recent opportunities tagged under it—Seminole County's procurement of naloxone and drug deactivation systems (IFB posted June 30, 2026) and Minnesota's multistate cooperative pharmaceutical and OTC product RFP (posted January 20, 2026)—are pharmaceutical and medical supply purchases that do not involve guaiacol benzoate as a line item or material input. Neither solicitation names the chemical by identifier or functional use, suggesting misclassification rather than genuine activity under this Commodity code.

The geographic spread of tagged activity spans Florida and Minnesota through a state agency cooperative purchasing vehicle (MMCAP), but the mismatch between the code's nominal scope and the actual work solicited renders geographic or issuing-body characterization uninformative for pursuing guaiacol benzoate business. No recent state or local solicitations show concrete demand for guaiacol benzoate itself. The code shows little relevant recent activity and should be deprioritized unless additional state or local opportunities emerge with explicit guaiacol benzoate specifications.